NASH is often characterized by multiple organ failure, with hepatic cirrhosis driving organ decompensation. But how do we know which organ decompensates first?

Read the article

We need to talk about the good and the bad fibroblasts.

Read the article

We believe it is time to put kidney fibrosis more in the center - even in diseases where other aspects (such as kidney volume) are the focus of attention.

Read the article

We have examined the effect of copper depletion therapy on the collagen microenvironment in breast cancer patients with high risk of relapse.

Read the article

If we are to develop precision medicine, we need to identify the right patients. Using Big Data is critical in clinical research, but there is a catch.

Read the article

Despite its pivotal role, the mechanical load is rarely a component of translational drug screening assays when testing novel osteoarthritis treatments. We want to change that!

Read the article

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.